Maverick Capital enjoyed a successful run in 2019, and if early 2020 is any indication the future remains bright for one of the hedge fund industry’s elite shops
... Read more »
Released at the Cayman Alternative Investment Summit in Grand Cayman this past week, an industry report on ESG initiatives has sparked discussion about how hedge funds can better implement an emerging set of responsible investing guidelines for institutional investors looking to do good by doing well
... Read more »
Whether the portfolio labels are hedge fund, marketable alternatives or absolute return what they all share at the typical university endowment portfolio is underwhelming performance numbers that on a fiscal basis may have caught CIOs off guard in 2019
... Read more »
Over the last few years institutional investors – particularly U.S. public pensions – have been on a shopping spree. They have piled billions of dollars in private debt/credit, which is a rare asset class where hedge fund and private equity managers seamlessly overlap
... Read more »
Often maligned biotech/life sciences hedge funds logged exceptional double digit returns in the last 12 months as other long/short equity managers struggled to even come close to the S&P 500’s 30% plus gains
... Read more »
